“CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19”. 2024. E Conference Zone, March, 34-35. https://econferencezone.org/index.php/ecz/article/view/2743.